Pragmatic randomized clinical trials: a proposal to enhance evaluation of new cancer therapies with early signs of exceptional activity

被引：12
|
作者：
Koehler, M. [1 ]
Donnelly, E. T. [2 ]
Kalanovic, D. [3 ]
Dagher, R. [4 ]
Rothenberg, M. L. [1 ]
机构：
[1] Pfizer Oncol, New York, NY 10017 USA
[2] Pfizer Oncol, Cambridge, MA USA
[3] Pfizer Oncol, Reg Med Affairs, Berlin, Germany
[4] Pfizer, Worldwide Safety & Regulatory, Groton, CT USA
来源：
ANNALS OF ONCOLOGY | 2016年 / 27卷 / 07期
关键词：
WORLD EFFECTIVENESS TRIAL; MULTIPLE-MYELOMA; DRUG DEVELOPMENT; SALFORD LUNG; BORTEZOMIB; PROTOCOL; AGE;
D O I：
10.1093/annonc/mdw143
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
We propose that for oncology drugs that demonstrate "exceptional activity" in Phase 1 or Phase 2 trials and receive accelerated/conditional approval and/or Breakthrough Therapy Designation, and for certain expanded indications, regulatory authorities should consider accepting data from prospectively-agreed pragmatic randomized clinical trials to grant full regulatory approval.
引用
收藏
页码：1342 / 1348
页数：7
相关论文
共 50 条
  • [31] Evaluation of rodent-only toxicology for early clinical trials with novel cancer therapeutics
    D R Newell
    S S Burtles
    B W Fox
    D I Jodrell
    T A Connors
    British Journal of Cancer, 1999, 81 : 760 - 768
  • [32] EPIC: an evaluation of the psychological impact of early-phase clinical trials in cancer patients
    Jittla, P.
    Graham, D. M.
    Zhou, C.
    Halliwell, J.
    O'Reilly, S.
    Aruketty, S.
    Azizi, A.
    Germetaki, T.
    Lowe, J.
    Little, M.
    Punnett, G.
    McMahon, P.
    Benson, L.
    Carter, L.
    Krebs, M. G.
    Thistlethwaite, F. C.
    Darlington, E.
    Yorke, J.
    Cook, N.
    ESMO OPEN, 2022, 7 (05)
  • [33] Evaluation of rodent-only toxicology for early clinical trials with novel cancer therapeutics
    Newell, DR
    Burtles, SS
    Fox, BW
    Jodrell, DI
    Connors, TA
    BRITISH JOURNAL OF CANCER, 1999, 81 (05) : 760 - 768
  • [34] Translating Physical Activity Interventions for Breast Cancer Survivors into Practice: An Evaluation of Randomized Controlled Trials
    White, Siobhan M.
    McAuley, Edward
    Estabrooks, Paul A.
    Courneya, Kerry S.
    ANNALS OF BEHAVIORAL MEDICINE, 2009, 37 (01) : 10 - 19
  • [35] Complementary/alternative therapies for the treatment of breast cancer. A systematic review of randomized clinical trials and a critique of current terminology
    Ernst, Edzard
    Schmidt, Katja
    Baum, Michael
    BREAST JOURNAL, 2006, 12 (06): : 526 - 530
  • [36] Quantitative evaluation of single-arm versus randomized phase II cancer clinical trials
    Pond, Gregory R.
    Abbasi, Saqib
    CLINICAL TRIALS, 2011, 8 (03) : 260 - 269
  • [37] Physical activity and early rehabilitation in hospitalized elderly medical patients: Systematic review of randomized clinical trials
    Martinez-Velilla, N.
    Cadore, E. L.
    Casas-Herrero, A.
    Idoate-Saralegui, F.
    Izquierdo, M.
    JOURNAL OF NUTRITION HEALTH & AGING, 2016, 20 (07): : 738 - 751
  • [38] Physical activity and early rehabilitation in hospitalized elderly medical patients: Systematic review of randomized clinical trials
    N. Martínez-Velilla
    E. L. Cadore
    Á. Casas-Herrero
    F. Idoate-Saralegui
    Mikel Izquierdo
    The journal of nutrition, health & aging, 2016, 20 : 738 - 751
  • [39] Transferring care to enhance access to early-phase cancer clinical trials: Protocol to evaluate a novel program
    Nwachukwu, Chika
    Makhnoon, Sukh
    Person, Marieshia
    Muthukrishnan, Meera
    Kazmi, Syed
    Anderson Jr, Larry D.
    Kaur, Gurbakhash
    Kapinos, Kandice A.
    Williams, Erin L.
    Fatunde, Oluwatomilade
    Sadeghi, Navid
    Robles, Fabian
    Basey, Alice
    Hulsey, Thomas
    Pruitt, Sandi L.
    Gerber, David E.
    CONTEMPORARY CLINICAL TRIALS COMMUNICATIONS, 2024, 39
  • [40] Computer modeling is no substitute for randomized clinical trials for decision making in early breast cancer hormonal therapy
    Vakaet, LAML
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (33) : 8543 - 8544
12345